๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The impact of ethnicity on the natural history of autoimmune hepatitis

โœ Scribed by Sumita Verma; Michael Torbenson; Paul J. Thuluvath


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
202 KB
Volume
46
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

โœฆ Synopsis


The impact of ethnicity on the natural history of autoimmune hepatitis (AIH) has not been well characterized. The aim of this study was to assess the natural history of AIH in blacks in comparison with others (nonblacks). This was a 10-year (June 1996 to June 2006) retrospective analysis of patients with AIH from a single tertiary care center. The diagnosis of AIH was defined by the criteria established by the International Autoimmune Hepatitis Club. A poor outcome was defined as liver failure at presentation, failure to achieve remission, need for liver transplantation, and/or death. One hundred one patients with AIH were eligible for the study. Black patients were more likely to have cirrhosis (56.7% versus 37.5%, P โ€ซุโ€ฌ 0.061), have liver failure at the initial presentation (37.8% versus 9.3%, P โ€ซุโ€ฌ 0.001), and be referred for liver transplantation (51.3% versus 23.4%, P โ€ซุโ€ฌ 0.004). The overall mortality was also significantly higher in black patients (24.3% versus 6.2%, P โ€ซุโ€ฌ 0.009). Compared with nonblacks, blacks had more advanced hepatic fibrosis (3.6 ุŽ 2.7 versus 2.1 ุŽ 2.4, P โ€ซุโ€ฌ 0.013). A Kaplan-Meier analysis showed that the probability of developing a poor outcome was significantly higher in blacks (P โ€ซุโ€ฌ 0.003). Independent predictors of poor outcome were black ethnicity, the presence of cirrhosis, and the fibrosis stage at presentation. Black males were the group most likely to have a poor outcome (85.7%). Conclusion: Blacks, especially black men with AIH, have more aggressive disease at the initial presentation, are less likely to respond to conventional immunosuppression, and have a worse outcome than nonblacks.


๐Ÿ“œ SIMILAR VOLUMES


Autoimmune hepatitis: Effect of symptoms
โœ Jordan J. Feld; Huong Dinh; Tamara Arenovich; Victoria A. Marcus; Ian R. Wanless ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 165 KB

Although the natural history of autoimmune hepatitis (AIH) has been characterized, little is known about patients who present asymptomatically. Consequently, whether they require immunosuppressive therapy with its associated complications is unclear. To compare the natural history of asymptomatic AI

The natural history of chronic hepatitis
โœ Brian J. McMahon ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 223 KB ๐Ÿ‘ 2 views

Chronic hepatitis B virus (HBV) infection has a complicated course. Three phases are identified: an immune tolerant phase with high HBV DNA and normal alanine aminotransferase (ALT) levels associated with minimal liver disease; an immune active phase with high HBV DNA and elevated ALT levels with ac

The natural history of hepatitis C cirrh
โœ Roberto J. Firpi; Virginia Clark; Consuelo Soldevila-Pico; Giuseppe Morelli; Ron ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 274 KB ๐Ÿ‘ 1 views

Hepatitis C after liver transplantation leads to graft cirrhosis in up to 30% of patients within 5 years, but limited data exist regarding the clinical course of cirrhosis after transplantation. The aims of this study were to report the natural history of hepatitis C cirrhosis after liver transplant

Serum autoantibodies in chronic hepatiti
โœ F Cassani; M Cataleta; P Valentini; P Muratori; F Giostra; R Francesconi; L Mura ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 164 KB

ANA-H and/or SMA-AA does not exclude AIH, the character-Antibodies to nuclei (ANA), smooth muscle (SMA), and ization of ANA and SMA may help to discriminate between liver/kidney microsomes type 1 (anti-LKM1) may occur in the two conditions. As compared with the seronegative counchronic hepatitis C.